Literature DB >> 17176919

Minimal change nephrotic syndrome in association with strongyloidiasis.

Y P Hsieh1, Y K Wen, M L Chen.   

Abstract

Although parasitic infections have been known to be associated with immune complex-mediated glomerular lesions, strongyloidiasis-related glomerulopathy has not been well documented. We report a patient with delayed-recognized disseminated strongyloidiasis who developed nephrotic syndrome 3 months after the beginning of the manifestations related to strongyloidiasis. A kidney biopsy showed minimal change disease. We treated strongyloidiasis and hesitated to give steroid therapy for the treatment of minimal change nephrotic syndrome (MCNS) because of the risk of aggravation of Strongyloides stercoralis infection. Surprisingly, resolution of heavy proteinuria occurred after anthelmintic therapy with ivermectin. This case suggests a possible causal relationship between S. stercoralis infection and MCNS. In addition, a review of another 4 cases previously reported in the literature demonstrates the importance of detecting underlying S. stercoralis infection in patients with nephrotic syndrome since steroid therapy can cause hyperinfection or disseminated strongyloidiasis, and which may lead to fatal outcome.

Entities:  

Mesh:

Year:  2006        PMID: 17176919     DOI: 10.5414/cnp66459

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

Review 1.  Strongyloidiasis: A Neglected Tropical Disease.

Authors:  Alejandro Krolewiecki; Thomas B Nutman
Journal:  Infect Dis Clin North Am       Date:  2019-03       Impact factor: 5.982

Review 2.  [Acute renal failure and rare severe complication of systemic steroid treatment in a 73-year-old woman].

Authors:  J Bramstedt; J U Becker; R Wrede; S Schmiedel; C Riemer; W Back
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

3.  Minimal change nephrotic syndrome in a patient with strongyloidiasis.

Authors:  Mieko Miyazaki; Masahito Tamura; Narutoshi Kabashima; Ryota Serino; Tatsuya Shibata; Tetsu Miyamoto; Yumi Furuno; Tetsuo Nishio; Jiro Ohara; Toshihiro Sakurai; Yutaka Otsuji
Journal:  Clin Exp Nephrol       Date:  2010-03-12       Impact factor: 2.801

Review 4.  Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Curr Opin Infect Dis       Date:  2012-08       Impact factor: 4.915

Review 5.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

6.  Strongyloides stercoralis infection in the immunocompromised host.

Authors:  Roshan Ramanathan; Thomas Nutman
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 7.  Strongyloidiasis: an emerging infectious disease in China.

Authors:  Chunmei Wang; Jiabao Xu; Xiaohong Zhou; Juan Li; Guiyun Yan; Anthony A James; Xiaoguang Chen
Journal:  Am J Trop Med Hyg       Date:  2013-03       Impact factor: 2.345

8.  Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report.

Authors:  Tahereh Malakoutian; Ronak Mohammadi; Mojgan Asgari; Atefeh Amouzegar
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

9.  Strongyloides stercoralis infection in transplanted patients.

Authors:  Seyed-Ali Sadjadi; Chitra Damodaran; Mohammad Sharif
Journal:  Am J Case Rep       Date:  2013-06-17

Review 10.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.